Abhik Datta
BioPharmaceutical Leader
Bangalore,KA
Summary
Strategic and results-driven leader with extensive expertise in biotechnology and biopharma industries. Proven track record in CMC and life cycle management of biologics. Adept at leading cross-functional teams, managing global operations, driving compliance, and fostering innovation. Skilled in stakeholder engagement, risk management, and delivering sustainable business outcomes.
Overview
17
17
years of professional experience
7
7
years of post-secondary education
Work History
Head of Operations - Biology (Deputy General Manager)
Syngene Amgen R & D Center, Syngene International Ltd
08.2020 - Current
- Lead a team of 65+ FTEs, ensuring operational excellence, resource optimization, and adherence to EHSS and quality compliance
- Oversee P&L management, business continuity planning, and risk mitigation strategies
- Implement Six Sigma Black Belt initiatives to enhance process efficiency
- Improved overall productivity with the introduction of innovative process improvement initiatives.
- Launched staff engagement, gender diversity and cultural programs in addition to robust reporting tool that increased operational quality.
- Implemented new systems for better data management, leading to improved decision-making processes.
Vice President – R&D Operations
Pandorum Technologies
10.2019 - 07.2020
- Directed R&D operations, fostering a collaborative environment for innovation
- Implemented cost optimization strategies, enhancing operational efficiency
Vice President – R&D
Stelis Bio-Pharma
05.2016 - 12.2018
- Led early-stage development of Kauliv (osteoporosis biosimilar), securing EMA authorization
- Managed strategic analysis and operating budgets for R&D initiatives
Head - R&D
Merck KGaA
05.2010 - 05.2016
- Directed CMC development activities, achieving significant advancements in biopharma services
- Recipient of Merck KGaA Emerging Talent Recognition for exceptional contributions
Functional Head
Avesthagen Ltd.
03.2008 - 04.2010
- Led cross-functional teams, driving innovation and operational excellence in biologics development
Education
MBA -
United Business Institute (UBI)
Europe 01.2011 - 12.2012
Ph.D. -
Indian Institute of Technology (IIT)
Kharagpur, India 01.1997 - 09.2001
Skills
Leadership of High Performing Teams
Biologics CMC and Life Cycle Management
Strategic Planning and Portfolio Expansion
EHSS and Quality Compliance
P&L and Risk Management
Stakeholder Engagement and Relationship Management
Operational Excellence and Continuous Improvement
Accomplishments
- 01/24, Six Sigma Black Belt, American Society for Quality (ASQ)
- 01/22, Syngene CEO Business Achievement Award
- 01/22, European Medical Agency (EMA) Authorization for osteoporosis biosimilar, KaulivTM (Lead team at Stelis Biopharma for development of KaulivTM)
- 01/12, Merck KGaA Emerging Talent Recognition
Selectedscientificpublications
- Proc Natl Acad Sci (PNAS) USA, 09/10, 107, 38, 16619-16624
- Oncogene, 02/08, 27, 8, 1135-1141
- J. Biol. Chem., 05/07, 282, 19, 14608-14815
- J. Biol. Chem., 08/06, 281, 33, 23414-23424
- Blood, 09/06, 108, 3, 1021-1029
- Blood, 09/04, 104, 8, 2523-2531
Timeline
Head of Operations - Biology (Deputy General Manager)
Syngene Amgen R & D Center, Syngene International Ltd
08.2020 - Current
Vice President – R&D Operations
Pandorum Technologies
10.2019 - 07.2020
Vice President – R&D
Stelis Bio-Pharma
05.2016 - 12.2018
MBA -
United Business Institute (UBI)
01.2011 - 12.2012
Head - R&D
Merck KGaA
05.2010 - 05.2016
Functional Head
Avesthagen Ltd.
03.2008 - 04.2010
Ph.D. -
Indian Institute of Technology (IIT)
01.1997 - 09.2001